Silencing the TLR4 gene can stop the process which may lead to cardiovascular disease in diabetic patients. Researchers carried out a series of in vitro tests which demonstrated that TLR4 plays a critical role in hyperglycaemic cardiac apoptosis, and that silencing the gene using specific small interfering RNA can prevent it.